All Pathways
Cardiothoracic SurgeryManagement

Bronchopleural Fistula Management (ESTS/Literature 2024)

Bronchopleural Fistula Management (ESTS/Literature 2024): Suspected Bronchopleural Fistula → Clinical Presentation → Diagnostic Workup → Timing & Size o...

Pathway Overview

12 steps

Algorithm Steps

12 total

  1. 01Start

    Suspected Bronchopleural Fistula

    Post-lung resection patient with persistent air leak or new pneumothorax

  2. 02Action

    Clinical Presentation

    Recognize BPF signs

    • EARLY BPF (day 1-7): usually mechanical failure
    • • Sudden large air leak
    • • Subcutaneous emphysema
    • • Tension physiology possible
    • LATE BPF (>7 days): usually infection-related
    • • Fever, cough with purulent sputum
    • • Productive cough laying on operative side
    • • Empyema with air-fluid level
  3. 03Action

    Diagnostic Workup

    Confirm BPF and assess size

    • CXR: new pneumothorax, air-fluid level change
    • CT chest: localize fistula, assess stump
    • Bronchoscopy: visualize stump, size fistula
    • Incidence (ESTS database):
    • • Overall: 1.9%
    • • Lobectomy: <1%
    • • Pneumonectomy: 4-20%
  4. 04Decision

    Timing & Size of BPF?

    Guides management approach

    • EARLY (1-7 days): mechanical failure → surgery
    • INTERMEDIATE (8-30 days): infection → drainage + consider surgery
    • LATE (>30 days): chronic → bronchoscopic or staged surgery
  5. 05Action

    Early BPF (Day 1-7)

    Mechanical stump failure

    • URGENT SURGICAL RE-EXPLORATION
    • • Stump revision/re-closure
    • • Buttress with viable tissue
    • - Intercostal muscle flap
    • - Pericardial fat pad
    • - Omentum
    • Best outcomes with early repair
  6. 06Action

    Surgical Repair

    Definitive closure

    • Stump revision with tissue coverage:
    • • Intercostal muscle flap (most common)
    • • Latissimus dorsi flap
    • • Serratus anterior flap
    • • Omental transposition
    • May require completion pneumonectomy
    • if residual lung non-functional
  7. 07Outcome

    Fistula Closed / Cavity Managed

    Long-term: pulmonary rehab, surveillance

  8. 08Action

    Late BPF (>7 days)

    Usually infection-related, staged approach

    • STEP 1: Sepsis control
    • • Open window thoracostomy (Eloesser flap)
    • • OR chest tube + irrigation
    • • VAC therapy to clean cavity
    • STEP 2: Fistula closure (once clean)
    • • Bronchoscopic intervention if small
    • • Surgical muscle flap if larger
  9. 09Action

    VAC Therapy

    For cavity management

    • Negative pressure wound therapy to:
    • • Clear empyema cavity
    • • Promote granulation
    • • Reduce cavity size
    • May allow eventual muscle flap closure
    • or space obliteration
  10. Path rejoins step 06Shared downstream outcome
  11. Path rejoins step 07Shared downstream outcome
  12. 10Action

    Bronchoscopic Interventions

    For small fistulas or poor surgical candidates

    • Options:
    • • Fibrin glue
    • • Endobronchial valves (one-way valves)
    • • Amplatzer device
    • • Coils
    • • Sclerotherapy
    • Success rate: variable, best for <8mm defects
    • Often temporizing measure
  13. Path rejoins step 06Shared downstream outcome
  14. Path rejoins step 07Shared downstream outcome
  15. Path rejoins step 10Shared downstream outcome
  16. 11Warning

    ⚠️ HIGH MORTALITY

    BPF mortality 16-72%. Early aggressive management improves outcomes.

  17. 12Action

    Initial Stabilization

    All patients

    • Chest tube drainage (if not present)
    • Position: operative side DOWN
    • Broad-spectrum antibiotics
    • Nutritional support
    • NPO if aspiration risk

Guideline Source

ESTS Database and Literature Synthesis - BPF Management

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • NO FORMAL GUIDELINES EXIST - management is institution/experience-based
  • Mortality 16-72% even with treatment
  • Treatment approach varies significantly between centers
  • Limited high-quality evidence for most interventions

Applicable Regions

USEU
Version 1Next review: 2027-01-11

Frequently Asked Questions

What is the Bronchopleural Fistula Management (ESTS/Literature 2024)?

The Bronchopleural Fistula Management (ESTS/Literature 2024) is a management clinical algorithm for Cardiothoracic Surgery. It provides a structured decision tree to guide clinical decision-making, based on ESTS Database and Literature Synthesis - BPF Management.

What guideline is the Bronchopleural Fistula Management (ESTS/Literature 2024) based on?

This algorithm is based on ESTS Database and Literature Synthesis - BPF Management (DOI: Literature-synthesis-2024).

What are the limitations of the Bronchopleural Fistula Management (ESTS/Literature 2024)?

Known limitations include: NO FORMAL GUIDELINES EXIST - management is institution/experience-based; Mortality 16-72% even with treatment; Treatment approach varies significantly between centers; Limited high-quality evidence for most interventions. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Bronchopleural Fistula Management (ESTS/Literature 2024) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free